Then, a clinical study has been performed describing increased binding of [18F]PM-PBB3 in dementia patients, reflecting cortical-dominant AD and subcortical-dominant progressive supranuclear palsy (PSP) Tau topologies. The gene discussed is MAPT; the disease is dementia.